ABSTRACT
Human Respiratory Syncytial Virus (hRSV), human Metapneumovirus (hMPV) and Adenovirus (ADV), are three of the most prevalent viruses responsible for pneumonia and bronchiolitis in children and elderly worldwide, accounting for a high number of hospitalizations annually. Diagnosis of these viruses is required to take clinical actions that allow an appropriate patient management. Thereby, new strategies to design fast diagnostic methods are highly required. In the present work, six monoclonal antibodies (mAbs, two for each virus) specific for conserved proteins from hRSV, hMPV and ADV were generated and evaluated through different immunological techniques, based on detection of purified protein, viral particles and human samples. In vitro evaluation of these antibodies showed higher specificity and sensitivity than commercial antibodies tested in this study. These antibodies were used to design a sandwich ELISA tests that allowed the detection of hRSV, hMPV, and ADV in human nasopharyngeal swabs. We observed that hRSV and ADV were detected with sensitivity and specificity equivalent to a current Direct Fluorescence Assay (DFA) methodology. However, hMPV was detected with more sensitivity than DFA. Our data suggest that these new mAbs can efficiently identify infected samples and discriminate from patients infected with other respiratory pathogens.
Subject(s)
Adenoviruses, Human/immunology , Antibodies, Monoclonal/immunology , Antibodies, Viral/immunology , Metapneumovirus/immunology , Respiratory Syncytial Virus, Human/immunology , Viral Proteins/immunology , Adenoviruses, Human/genetics , Animals , Cell Line , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique , Humans , Metapneumovirus/genetics , Mice , Respiratory Syncytial Virus, Human/genetics , Sensitivity and SpecificityABSTRACT
BACKGROUND: Between September 2000 and November 2005, approximately 10% of the retrospectively examined human adenovirus (HAdV)-positive pediatric cases of acute respiratory disease (ARD) requiring hospitalization at the Hospital Nacional de Pediatria Juan P. Garrahan in Buenos Aires, Argentina, were found to have a HAdV-B2 infection. OBJECTIVE: To characterize genetically and antigenically the HAdV-B2 virus isolates. STUDY DESIGN: Restriction enzyme analysis (REA), hexon and fiber gene sequencing and virus neutralization assays (VN) were carried out on 8 HAdV-B2 respiratory virus isolates. RESULTS: REA showed that the 8 examined HAdV-B2 virus isolates were HAdV11, belonging to two genomic variants: HAdV11a and a BclI variant of HAdV11c which we designated 11c4. Molecular analysis of the hexon genes showed that both REA variants had a HAdV11-like hexon gene. Confirming previous reports, the 7 HAdV11a virus isolates were found to have HAdV14-like fiber genes and therefore are HAdV H11/F14. The fiber gene of the HAdV11c4 virus isolates most closely resembled that of various strains of HAdV7. In VN assays, the 4 tested HAdV11a strains were serotyped as HAdV11-14. The HAdV11c4 strain was serotyped as HAdV11 but also showed a weak but significant reactivity with antiserum to HAdV7. Compared with the other HAdV-positive cases in our study, infection with HAdV11 caused a similarly severe disease. CONCLUSIONS: Our results provide evidence to the long term world-wide circulation of HAdV H11/F14 as a causative agent of ARD. Combined, our molecular and serology data support the rationale to base the molecular typing and designation of recombinant viruses on the sequences of the hexon and fiber genes.
Subject(s)
Adenoviridae Infections/virology , Adenoviruses, Human/classification , Respiratory Tract Diseases/virology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adenoviruses, Human/isolation & purification , Argentina , Child , Child, Preschool , DNA, Viral/chemistry , DNA, Viral/genetics , Female , Genotype , Humans , Infant , Male , Molecular Epidemiology , Molecular Sequence Data , Neutralization Tests , Polymorphism, Restriction Fragment Length , Prohibitins , Sequence Analysis, DNA , SerotypingABSTRACT
BACKGROUND: adenoviruses are among the most promising vectors for the development of an HIV vaccine. The results of the phase IIB study of the adenovirus serotype 5-based Merck Trivalent HIV vaccine have raised the concern that serological immunity to adenovirus serotype 5 (Ad5) could be linked to HIV acquisition risk in high-risk individuals. We examined the association between adenovirus serostatus and the rate of incident HIV infection in populations at elevated risk of HIV acquisition. METHODS: we performed a nested case-control study of Ad5 serostatus among 299 HIV-infected and 590 matched HIV-uninfected persons participating in the Multicenter AIDS Cohort Study (MACS) and in HPTN 039, a study of herpes simplex virus 2 suppression among adults in the United States, South America, and Africa. Appropriate HIV cases and controls were identified in each cohort, and Ad5-neutralizing antibody titers were compared in these two groups. RESULTS: in MACS and HPTN 039, the relative risks of incident HIV infection among Ad5-seropositive vs. Ad5-seronegative individuals were 1.1 (95% confidence interval 0.8-1.5, P = 0.57) and 1.0 (95% confidence interval 0.4-2.3, P = 0.99), respectively. HIV-1 acquisition rates did not vary significantly by Ad5-neutralizing antibody titer. CONCLUSION: the presence of Ad5-neutralizing antibodies is not linked to the risk of HIV acquisition among populations at elevated risk of HIV infection.
Subject(s)
AIDS Vaccines/immunology , Adenoviridae Infections/immunology , Adenoviruses, Human/immunology , Antibodies, Neutralizing/immunology , HIV Seropositivity/immunology , HIV-1/pathogenicity , AIDS Vaccines/blood , Adenoviridae Infections/blood , Adenoviridae Infections/genetics , Adenoviruses, Human/genetics , Adult , Africa , Antibodies, Neutralizing/blood , Case-Control Studies , Female , Genetic Vectors , Humans , Male , Risk Assessment , South America , United StatesABSTRACT
Adenovirus (AdV) respiratory infections are usually described as being associated with high mortality rates. Laboratory diagnosis is essential for the establishment of the appropriate therapy, and for guiding the implementation of preventive measures in order to prevent the spread of the infection. Aiming to analyze the sensitivity and specificity of the laboratorial diagnosis methods available, we compared antigen detection by indirect immunofluorescence assay (IF), and a specific nested polymerase chain reaction (PCR), to detect AdV in respiratory samples collected from patients admitted to hospital with acute respiratory disease. Positive samples were inoculated into a cell culture to confirm the results. We analyzed 381 samples from the nasopharyngeal aspirates collected during the year 2008; of these, 2.6 percent tested were positive for adenovirus through IF and 10 percent through PCR; positive isolation was obtained in 40 percent and 26 percent of these cases, respectively. Most infected patients were children under six months of age, and despite of the fact that a significant number of patients required intensive care, the mortality rate was low (5 percent). In conclusion, molecular methods were found to be useful for rapid diagnosis of adenovirus infections with higher sensitivity than antigen detection; their introduction permitted a significant increase in diagnoses of adenovirus infections.
Infecções respiratórias por Adenovírus (ADV) são geralmente descritas associadas com alta mortalidade. O diagnóstico laboratorial é essencial para o estabelecimento da terapêutica adequada e para orientar a implantação de medidas preventivas evitando a propagação da infecção. Com o objetivo de analisar a sensibilidade e a especificidade dos métodos de avaliação de diagnóstico laboratorial, foi comparada a detecção de antígeno por imunofluorescência indireta (IF) com a reação em cadeia da polimerase específica (PCR) para detectar AdV em amostras respiratórias coletadas de pacientes internados com doença respiratória aguda. As amostras com resultados positivos foram inoculadas em cultura celular. Foram analisadas 381 amostras da secreção nasofaríngea coletadas durante o ano de 2008, das quais 2,6 por cento foram positivas pela IF e 10 por cento pela PCR, isolamento positivo foi obtido em 40 por cento e 26 por cento dos casos positivos pelos testes anteriores, respectivamente. A maioria dos pacientes infectados eram crianças com menos de seis meses de idade, e apesar do fato de que um número significativo de pacientes necessitou de cuidados intensivos, a taxa de mortalidade foi baixa (5 por cento). Em conclusão, os métodos moleculares são úteis para o diagnóstico rápido de infecções por adenovírus com maior sensibilidade do que a detecção do antígeno, a sua introdução na rotina permitiu um aumento significativo no diagnóstico de infecções por adenovírus.
Subject(s)
Child , Child, Preschool , Humans , Infant , Adenoviruses, Human , Adenovirus Infections, Human/diagnosis , Nasopharynx/virology , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/virology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adenoviruses, Human/isolation & purification , Cross-Sectional Studies , Fluorescent Antibody Technique, Indirect , Polymerase Chain Reaction , Prospective Studies , Sensitivity and SpecificityABSTRACT
Vaccines based on adenovirus (Ad) vectors are currently in development against several pathogens. However, neutralizing antibodies (NAb) to human adenovirus type 5 (AdHu5), the best-studied vector, are highly prevalent in humans worldwide. Less-prevalent adenoviruses, including human and simian serotypes, provide alternative vaccine platforms. In this study, sera from 200 Brazilian human subjects and New-World monkeys were tested for NAb titers to human serotypes AdHu5 and AdHu26 and chimpanzee-origin Ad viruses of serotype 6 (AdC6) and serotype 68 (AdC68). Seroprevalence rates of NAb in humans were 69.5% for AdHu5, 44% for AdHu26, 21% for AdC6 and 23.5% for AdC68. In addition, NAb titers to human Ad were consistently higher than those found to simian serotypes. Surprisingly, sera from some New-World monkey species were able to neutralize AdC6 and/or AdC68. A possible explanation for these findings and the implications for the development of Ad-vector vaccines are discussed in detail.
Subject(s)
Adenoviridae Infections/immunology , Adenoviridae Infections/veterinary , Adenoviruses, Human/immunology , Adenoviruses, Simian/immunology , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Primate Diseases/immunology , Adolescent , Adult , Aged , Animals , Brazil , Female , Humans , Male , Middle Aged , Platyrrhini , Primate Diseases/virology , Seroepidemiologic Studies , Young AdultABSTRACT
The adenoviruses are frequently associated with sporadic gastroenteritis outbreaks in different parts of the world. This study aimed at the molecular characterization of human adenoviruses (HAdV) species and serotypes, in fecal samples from children, by multiplex-PCR and by PCR-RFLP, respectively, followed by genomic sequencing. Of 39 adenovirus-positive samples, 30 (76.9%) were classified as species F, six (15.4%) as species C, and two (5.1%) as species A, and one (2.6%) had a mixed F/C pattern. The serotyping showed that 14 (41.2%) were HAdV-41, 15 (44.1%) were HAdV-40, five (14.7%) were HAdV-5, and five samples could not be serotyped. This is the first study to molecularly characterize HAdV in the Central West region of Brazil, and the results highlight the circulation of the HAdV-5 among children with acute gastroenteritis in this region.
Subject(s)
Adenoviridae Infections/virology , Adenoviruses, Human/classification , Adenoviruses, Human/isolation & purification , Feces/virology , Gastroenteritis/virology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Brazil , Child, Preschool , DNA Fingerprinting , DNA, Viral/genetics , Genotype , Humans , Infant , Phenotype , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Sequence Analysis, DNA , SerotypingABSTRACT
To date, human adenoviruses are classified into 53 types (types 1-51 and types 53 and 54), which have been grouped into six species named A through F, and the recently identified type 52 has been proposed as member of a new species, G. Type classification is based on type-specific epitopes within loop 1 (L1) and loop 2 (L2) of the hexon protein, which contain seven hypervariable regions that are responsible for type specificity. In this paper, we present the characterization of an adenovirus strain isolated from a male AIDS patient in Cordoba, Argentina. This strain was found to be a member of species D by genomic Sma I restriction analysis. Sequencing of the L1 and L2 regions of the hexon gene and immunological characterization by virus neutralization revealed this hexon to be unique and distinct from the previously identified hexons of types within species D. A seroepidemiologic study in the human population of Cordoba showed that this strain was not endemic in the local human population.
Subject(s)
AIDS-Related Opportunistic Infections/virology , Acquired Immunodeficiency Syndrome/complications , Adenoviruses, Human/isolation & purification , Capsid Proteins/genetics , Acquired Immunodeficiency Syndrome/virology , Adenoviruses, Human/classification , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adult , Capsid Proteins/immunology , Cell Line , Feces/virology , Humans , Male , Molecular Sequence Data , PhylogenyABSTRACT
Adenovirus (AdV) respiratory infections are usually described as being associated with high mortality rates. Laboratory diagnosis is essential for the establishment of the appropriate therapy, and for guiding the implementation of preventive measures in order to prevent the spread of the infection. Aiming to analyze the sensitivity and specificity of the laboratorial diagnosis methods available, we compared antigen detection by indirect immunofluorescence assay (IF), and a specific nested polymerase chain reaction (PCR), to detect AdV in respiratory samples collected from patients admitted to hospital with acute respiratory disease. Positive samples were inoculated into a cell culture to confirm the results. We analyzed 381 samples from the nasopharyngeal aspirates collected during the year 2008; of these, 2.6% tested were positive for adenovirus through IF and 10% through PCR; positive isolation was obtained in 40% and 26% of these cases, respectively. Most infected patients were children under six months of age, and despite of the fact that a significant number of patients required intensive care, the mortality rate was low (5%). In conclusion, molecular methods were found to be useful for rapid diagnosis of adenovirus infections with higher sensitivity than antigen detection; their introduction permitted a significant increase in diagnoses of adenovirus infections.
Subject(s)
Adenovirus Infections, Human/diagnosis , Adenoviruses, Human , Nasopharynx/virology , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/virology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adenoviruses, Human/isolation & purification , Child , Child, Preschool , Cross-Sectional Studies , Fluorescent Antibody Technique, Indirect , Humans , Infant , Polymerase Chain Reaction , Prospective Studies , Sensitivity and SpecificityABSTRACT
Replication-defective adenoviruses have been utilized as candidate HIV vaccine vectors. Few studies have described the international epidemiology of pre-existing immunity to adenoviruses. We enrolled 1904 participants in a cross-sectional serological survey at seven sites in Africa, Brazil, and Thailand to assess neutralizing antibodies (NA) for adenovirus types Ad5, Ad6, Ad26 and Ad36. Clinical trial samples were used to assess NA titers from the US and Europe. The proportions of participants that were negative were 14.8% (Ad5), 31.5% (Ad6); 41.2% (Ad26) and 53.6% (Ad36). Adenovirus NA titers varied by geographic location and were higher in non-US and non-European settings, especially Thailand. In multivariate logistic regression analysis, geographic setting (non-US and non-European settings) was statistically significantly associated with having higher Ad5 titers; participants from Thailand had the highest odds of having high Ad5 titers (adjusted OR=3.53, 95% CI: 2.24, 5.57). Regardless of location, titers of Ad5NA were the highest and Ad36 NA were the lowest. Coincident Ad5/6 titers were lower than either Ad5 or Ad6 titers alone. Understanding pre-existing immunity to candidate vaccine vectors may contribute to the evaluation of vaccines in international populations.
Subject(s)
Adenovirus Infections, Human/epidemiology , Adenoviruses, Human/immunology , Antibodies, Viral/blood , Adenoviruses, Human/classification , Adolescent , Adult , Africa/epidemiology , Antibodies, Neutralizing/blood , Brazil/epidemiology , Cross-Sectional Studies , Europe/epidemiology , Female , Geography , Humans , Male , Middle Aged , Regression Analysis , Seroepidemiologic Studies , Thailand/epidemiology , United States/epidemiology , Young AdultABSTRACT
From January to December 1998, nasopharyngeal aspirates were obtained from 482 children with acute respiratory infections attended in emergence department and wards of a teaching hospital in the city of Salvador, Brazil. The samples were tested for the presence of adenovirus by isolation in tissue culture and indirect immunofluorescence assay. Eleven adenoviruses were detected by both methods in the same clinical samples. Infections by adenovirus were observed during seven months of the year without association with rainy season. Genome analysis was performed on these 11 isolates. Species C was represented by serotypes 1, 2 and 5. Within species B, only serotype 7 (Ad7) was detected. Two genomic variants of Ad1, two variants of Ad2, one of Ad5, and one of Ad7 (7h) were identified. This is the first study of molecular epidemiology of adenovirus associated to acute respiratory infections in children living in Northeast Brazil, and contributes to a better understanding of adenovirus infections in the country.
Subject(s)
Child , Humans , Adenoviruses, Human , Adenovirus Infections, Human/virology , Respiratory Tract Infections/virology , Acute Disease , Adenovirus Infections, Human/epidemiology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adenoviruses, Human/isolation & purification , Brazil/epidemiology , DNA, Viral/analysis , Fluorescent Antibody Technique, Indirect , Genotype , Nasopharynx/virology , Respiratory Tract Infections/epidemiologyABSTRACT
PURPOSE: To evaluate the RPS Adenodetector, a rapid immunochromatographic test, in the diagnosis of patients with clinical overt adenoviral conjunctivitis. METHODS: Consecutive case series. Patients underwent conjunctiva scraping for RPS Adenodetector test and culture to identify adenovirus. RESULTS: A total of 11 patients were studied, and 10 had unilateral disease. Five (45.5%) had symptoms for 2 days, 5 for three days, and 1 for 7 days. Adenovirus culture was positive in 8 patients (73%) and RPS Adenodetector was positive in 9 (82%) patients. Eight patients had adenovirus identification by both methods. In one patient the RPS Adenodetector was positive in contrast to a negative culture. The two patients revealing negative RPS Adenodetector results also had negative cultures. The sensitivity was 100% and the specificity was 67%. CONCLUSION: The RPS Adenodetector is a useful tool in the rapid diagnosis of adenovirus conjunctivitis and may contribute to the spread control of this highly contagious disease.
Subject(s)
Adenovirus Infections, Human/diagnosis , Adenoviruses, Human/isolation & purification , Conjunctivitis, Viral/diagnosis , Diagnostic Techniques, Ophthalmological , Adenovirus Infections, Human/virology , Adenoviruses, Human/immunology , Adolescent , Adult , Antigens, Viral/analysis , Conjunctivitis, Viral/virology , Female , Humans , Male , Prospective Studies , Reagent Kits, Diagnostic , Sensitivity and Specificity , Virus CultivationABSTRACT
OBJETIVO: Avaliar a utilização do RPS Adenodetector®, como método diagnóstico de pacientes com quadro clínico de conjuntivite adenoviral. MÉTODOS: Análise de série de casos consecutivos de pacientes com diagnóstico clínico de ceratoconjuntivite adenoviral submetidos comparativamente ao teste RPS Adenodetector® e a raspado conjuntival para cultura de vírus. RESULTADOS: Dos 11 pacientes avaliados, 10 pacientes apresentavam acometimento unilateral. Em relação ao tempo de início dos sintomas no momento da colheita, 5 (45,5 por cento) pacientes apresentavam dois dias de história, 5 (45,5 por cento) apresentavam três dias e 1 (9,1 por cento) apresentava 7 dias. A cultura para adenovírus foi positiva em 8 pacientes (73 por cento) e o RPS Adenodetector® foi positivo em 9 pacientes (82 por cento). Oito pacientes apresentaram o teste rápido e cultura positiva. Um paciente apresentou teste RPS Adenodetector® positivo com cultura negativa. Os dois pacientes com teste RPS Adenodetector® negativo apresentaram cultura negativa. O RPS Adenodetector® mostrou sensibilidade de 100 por cento e especificidade de 67 por cento adotando-se a cultura de vírus como exame padrão-ouro para o diagnóstico de conjuntivite adenoviral. CONCLUSÃO: O RPS Adenodetector® foi útil para o diagnóstico de conjuntivite adenoviral e pode auxiliar na orientação do paciente quanto ao contágio e disseminação da doença.
PURPOSE: To evaluate the RPS Adenodetector®, a rapid immunochromatographic test, in the diagnosis of patients with clinical overt adenoviral conjunctivitis. METHODS: Consecutive case series. Patients underwent conjunctiva scraping for RPS Adenodetector® test and culture to identify adenovirus. RESULTS: A total of 11 patients were studied, and 10 had unilateral disease. Five (45.5 percent) had symptoms for 2 days, 5 for three days, and 1 for 7 days. Adenovirus culture was positive in 8 patients (73 percent) and RPS Adenodetector® was positive in 9 (82 percent) patients. Eight patients had adenovirus identification by both methods. In one patient the RPS Adenodetector® was positive in contrast to a negative culture. The two patients revealing negative RPS Adenodetector® results also had negative cultures. The sensitivity was 100 percent and the specificity was 67 percent. CONCLUSION: The RPS Adenodetector® is a useful tool in the rapid diagnosis of adenovirus conjunctivitis and may contribute to the spread control of this highly contagious disease.
Subject(s)
Adolescent , Adult , Female , Humans , Male , Adenovirus Infections, Human/diagnosis , Adenoviruses, Human/isolation & purification , Conjunctivitis, Viral/diagnosis , Diagnostic Techniques, Ophthalmological , Adenovirus Infections, Human/virology , Adenoviruses, Human/immunology , Antigens, Viral/analysis , Conjunctivitis, Viral/virology , Prospective Studies , Reagent Kits, Diagnostic , Sensitivity and Specificity , Virus CultivationABSTRACT
From January to December 1998, nasopharyngeal aspirates were obtained from 482 children with acute respiratory infections attended in emergence department and wards of a teaching hospital in the city of Salvador, Brazil. The samples were tested for the presence of adenovirus by isolation in tissue culture and indirect immunofluorescence assay. Eleven adenoviruses were detected by both methods in the same clinical samples. Infections by adenovirus were observed during seven months of the year without association with rainy season. Genome analysis was performed on these 11 isolates. Species C was represented by serotypes 1, 2 and 5. Within species B, only serotype 7 (Ad7) was detected. Two genomic variants of Ad1, two variants of Ad2, one of Ad5, and one of Ad7 (7h) were identified. This is the first study of molecular epidemiology of adenovirus associated to acute respiratory infections in children living in Northeast Brazil, and contributes to a better understanding of adenovirus infections in the country.
Subject(s)
Adenovirus Infections, Human/virology , Adenoviruses, Human , Respiratory Tract Infections/virology , Acute Disease , Adenovirus Infections, Human/epidemiology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adenoviruses, Human/isolation & purification , Brazil/epidemiology , Child , DNA, Viral/analysis , Fluorescent Antibody Technique, Indirect , Genotype , Humans , Nasopharynx/virology , Respiratory Tract Infections/epidemiologyABSTRACT
There is no vaccine licensed for human use to protect laboratory or field workers against infection with Venezuelan equine encephalitis virus (VEEV). Infection of these groups is most likely to occur via the airborne route and there is evidence to suggest that protection against airborne infection may require high antibody levels and the presence of antibody on the mucosal surface of the respiratory tract. Recombinant defective type 5 adenoviruses, expressing the E3E26K structural genes of VEEV were examined for their ability to protect mice against airborne challenge with virulent virus. After intranasal administration, good protection was achieved against the homologous serogroup 1A/B challenge virus (strain Trinidad donkey). There was less protection against enzootic serogroup II and III viruses, indicating that inclusion of more than one E3E26K sequence in a putative vaccine may be necessary. These studies confirm the potential of recombinant adenoviruses as vaccine vectors for VEEV and will inform the development of a live replicating adenovirus-based VEEV vaccine, deliverable by a mucosal route and suitable for use in humans.
Subject(s)
Adenoviruses, Human/genetics , Antigens, Viral/genetics , Defective Viruses/genetics , Encephalitis Virus, Venezuelan Equine/genetics , Encephalitis Virus, Venezuelan Equine/immunology , Viral Envelope Proteins/biosynthesis , Viral Envelope Proteins/genetics , Viral Vaccines/genetics , Adenoviruses, Human/immunology , Administration, Intranasal , Animals , Antigens, Viral/administration & dosage , Antigens, Viral/immunology , Cell Line, Tumor , Defective Viruses/classification , Encephalitis Virus, Venezuelan Equine/pathogenicity , Encephalomyelitis, Venezuelan Equine/immunology , Encephalomyelitis, Venezuelan Equine/prevention & control , Encephalomyelitis, Venezuelan Equine/virology , Humans , Immunization Schedule , Mice , Mice, Inbred BALB C , Serotyping , Species Specificity , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Viral Envelope Proteins/immunology , Viral Vaccines/administration & dosage , Viral Vaccines/immunology , Virulence , Virus Replication/genetics , Virus Replication/immunologyABSTRACT
BACKGROUND: Acute lower respiratory infection (ALRI) is one of the main causes of morbidity and mortality in small children. OBJECTIVE: The aim of this study was to determine the frequency, seasonality and association with clinical entities of respiratory syncytial virus (RSV) and adenoviruses in children with ALRI. STUDY DESIGN: During 2 consecutive years (1991-1992), 168 children under 2 years of age hospitalized due to ALRI in a public pediatric hospital of Buenos Aires, Argentina, were studied. RSV and adenoviruses were investigated on nasopharyngeal aspirates (NPA) by indirect immunofluorescence (IIF). HEp-2 cells were used for adenovirus isolation. RESULTS: RSV was detected in 36.3% and adenoviruses in 14.3% of the cases (P < 0.0001). All adenoviruses detected by IIF were also isolated in culture. Out of 61 RSV cases, 57% corresponded to bronchiolitis and 43% to pneumonia. Ninety-two per cent of children with RSV were less than 1 year old and 70% were less than 5 months. The highest number of RSV cases were observed during winter, with a clear peak in July. Seventy-one per cent of adenovirus cases were associated with pneumonia and only 24% with bronchiolitis (P < 0.02), and predominated in children older than 5 months of age (P < 0.0001). Adenoviruses were detected in almost all months of the year with a small peak at the end of winter and beginning of spring. No significant differences in clinical features at admission, breast feeding or malnutrition were observed among children with RSV or adenovirus diagnosis versus those with no viral etiology. The overall fatality rate was 2.4%. In all fatal cases adenovirus was detected in NPA. Thus, fatality rate among patients with adenoviruses reached 16.7%. CONCLUSIONS: Our findings show the importance of RSV and adenoviruses associated with ALRI in hospitalized children under 2 years of age and the different epidemiological patterns of the two viruses in Buenos Aires, Argentina.
Subject(s)
Adenovirus Infections, Human/epidemiology , Adenoviruses, Human , Bronchiolitis, Viral/epidemiology , Pneumonia, Viral/epidemiology , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus, Human , Acute Disease , Adenovirus Infections, Human/immunology , Adenoviruses, Human/immunology , Argentina/epidemiology , Bronchiolitis, Viral/immunology , Female , Fluorescent Antibody Technique, Indirect , Hospitals, Pediatric , Hospitals, Public , Humans , Infant , Male , Pneumonia, Viral/immunology , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Virus, Human/immunology , SeasonsABSTRACT
A study about the incidence of Adenovirus on viral conjunctivitis was conducted. A sample design was made and samples of conjunctival exudate were taken from 150 patients with diagnosis of apparently viral conjunctivitis at the "Ramón Pando Ferrer" Ophthalmological Hospital from July to December, 1994. Samples were inoculated in cell culture and the indirect immunofluorescence technique was applied to those with a cytopathogenic effect that suggested infection due to Adenovirus. Monoclonal antibodies were used against Adenovirus allowing to identify them as part of the Adenoviridae family. The hemagglutination technique was used with erythrocytes of monkeys and rats as an indicator system in order to group the isolates previously identified by the indirect immunofluorescence technique. Later on, it was made an analysis by restriction enzymes of the viral genome to enable typing. The results of this study showed an incidence of Adenovirus on viral conjunctivitis of 20%, with a confidence interval between 14 and 26% and a reliability index of 95%. It was proved that serotype 37 caused conjunctivitis more frequently.
Subject(s)
Adenovirus Infections, Human/epidemiology , Conjunctivitis, Viral/epidemiology , Adenovirus Infections, Human/virology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Adenoviruses, Human/isolation & purification , Conjunctivitis, Viral/virology , Cuba/epidemiology , DNA, Viral/analysis , DNA, Viral/isolation & purification , Fluorescent Antibody Technique, Indirect , Genome, Viral , Hemagglutination Tests , Humans , Incidence , Random Allocation , Restriction Mapping , SerotypingABSTRACT
Las infecciones respiratorias por virus respiratorio sincicial (VRS) y adenovirus (Ad) son la principal causa de morbimortalidad entre las infecciones respiratorias agudas bajas (RAB) de la infancia. Ambos virus pueden dejas secuelas, al VRS se le ha atribuido desencadenar obstrucción bronquial persistente y al Ad, especialmente el Ad7h, bronquectasias, fibrosis y daño pulmonar crónico. Los mecanismos por los que estos virus pueden producir estas secuelas no se conocen, pero hay evidencias que sugieren que ésta sea causada por un mecanismo inmunológico, dependiente del tipo de virus y de la respuesta del huésped. El objetivo de este trabajo fue determinar el tipo de respuesta inmune frente a la infección por VRS y Ad mediante la cuantificación de interferón-gamma (IFN-gamma) e interleuquina-4 (IL-4), citoquinas marcadas de respuesta inmune celular y humoral respectivamente. Las ILs fueron cuantificadas en el sobrenadante de cultivo de células mononucleadas de sangre periférica infectadas o no infectadas in vitro con VRS, Ad3, Ad7h y control con mitógeno (PHA) y de células mononucleadas de lactantes con infección natural por VRS y grupo control estimuladas o no con mitógenos (PHA y PWN). Los lactantes con IRAB por VRS presentaron una disminución significativa en la producción de IFN-gamma e IL-4 por células mononucleadas no estimuladas y estimuladas con PHA. Esta disminución fue mayor para el IFN-gamma que para la IL-4, por lo que la relación IFN eta/IL-4 fue menor en estos lactantes. La producción de IL-4 pero no la de IFN-eta de los lactantes infectados con VRS que tenían antecedentes de atopia (p< 0,02). Las células mononucleadas de niños sanos infectadas in vitro con Ad estimulan la producción de IFN-gamma pero no la de IL-4 y con Ad7h, responden con una producción de IFN-gamma en este modelo in vitro. Estos resultados sugieren que la respuesta del sistema inmune frente a la infección viral dependerá del tipo de virus infectante y de la variabilidad genética del individuo. Esto demuestra la importancia de estudiar la respuesta inmune de cada virus en los diferentes individuos ya que el resultado de protección o daño dependerá de la interrelación huésped-virus
Subject(s)
Humans , Adenoviruses, Human/immunology , In Vitro Techniques , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , Respiratory Syncytial Viruses/immunology , Adenoviruses, Human/pathogenicity , Antibody Formation , Immunity, Cellular , Interferon-gamma/immunology , Interleukin-4/immunology , Leukocytes, Mononuclear/metabolism , Host-Parasite Interactions , Respiratory Syncytial Viruses/pathogenicityABSTRACT
It was possible to standardize a procedure which combined an indirect microELISA assay with a standard curve and that allowed to estimate the titre of IgG antibodies to Adenovirus in samples of human serum, using only one dilution of these. Based on the end-point titre previously determined for a panel of 117 serum samples, we selected 90 of these samples (r2 = 0.98) to build 4 standard curves that related the natural logarithm of the fluorescence responses to the natural logarithm of the end-point titre for a wide range of serum dilutions (1:40 = 1:320). It was selected the curve corresponding to serum dilution 1:40 (r2 = 0.81), which made possible an optimum utilization of those accessories designed to handle the volumes in the ultramicro range and, therefore, the automation of the whole procedure. The results obtained as regards the complement fixation test (100% of sensitivity and 97.3% of specificity) support the use of this method in our laboratory as a complementary tool to carry out seroepidemiological studies on a large scale and with diagnostic ends.
Subject(s)
Adenoviruses, Human/immunology , Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay/methods , Immunoglobulin G/blood , Adenovirus Infections, Human/diagnosis , Adenovirus Infections, Human/immunology , Adolescent , Adult , Algorithms , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Reference ValuesABSTRACT
To explore the pathogenic mechanisms involved in adenovirus infection, we evaluated total levels of immunoglobulins, antiadenovirus antibodies, adenovirus-specific circulating immune complexes, and cytokines in serum samples obtained from 38 hospitalized children with adenovirus infection. According to their clinical findings and outcome, the infections were classified as follows: (1) moderate (group I, n = 10), (2) severe (group II, n = 12), and (3) fatal (group III, n = 16). About 60% of the children had elevated IgM levels. IgG-containing adenovirus-specific circulating immune complexes were initially detected in 7 of 16 group III patients, 4 of whom had low serum levels of the third component of complement. A decrease in initial antiadenovirus IgG antibodies was observed in 3 of 10 patients in group III. Serum interleukin-6 was not detected in group I (none of 10), but was present in group II (7 of 12, p = 0.016) and group III (13 of 16, p < 0.001). Interleukin-8 was detected in all groups; values in fatal cases were significantly higher than in surviving children. Tumor necrosis factor alpha was not observed in group I (none of 10) and was uncommon in group II (2 of 12) but was frequently detected in group III (9 of 15, p = 0.01). Interleukin-1 and interleukin-4 were rarely detected in serum samples. Increased concentrations of interleukin-6, interleukin-8, and tumor necrosis factor alpha were associated with hypoperfusion, febrile peaks, tonic-clonic seizures, and septic shock. In 5 of 10 patients in groups II and III, autoantibodies specific for smooth muscle were found. Our findings indicate that high serum values for interleukin-6, interleukin-8, and tumor necrosis factor alpha are associated with severity of adenovirus infection.